Back to Melanotan-ii research
melanotan-ii melanocortin agonist preclinical animal n preclinical 2026-04-03 PubMed

Brain's Melanocortin Receptors Boost Energy Burn and Muscle Heat

Ventromedial hypothalamic melanocortin receptor activation: regulation of activity energy expenditure and skeletal muscle thermogenesis.

Background

The ventromedial hypothalamus (VMH) is a critical brain region involved in regulating energy balance, often referred to as the 'satiety center.' Within the VMH, melanocortin receptors play a key role in controlling appetite and metabolism. While their influence on food intake is well-established, the precise mechanisms by which VMH melanocortin receptor activation impacts activity energy expenditure (AEE) and skeletal muscle thermogenesis (heat production) have remained less clear.

Results

Activation of VMH melanocortin receptors significantly increased energy expenditure and thermogenesis. Compared to controls, mice receiving MTII showed a 25% increase in activity energy expenditure (AEE) over 24 hours (p<0.01). This was accompanied by a 1.5°C elevation in skeletal muscle temperature (p<0.001), indicating enhanced thermogenesis. Overall, the study found that VMH melanocortin receptor activation led to a significant 25% increase in activity energy expenditure, demonstrating a direct link between this brain region and physical energy output. Furthermore, oxygen consumption, a direct measure of metabolic rate, was elevated by 18% in the MTII group (p<0.05), without a corresponding increase in locomotor activity, suggesting a shift towards less efficient energy use or increased heat production. These effects were sustained for at least 12 hours post-injection.

Why It Matters

This study provides crucial insights into how the brain's melanocortin system can directly influence peripheral energy expenditure and heat production, independent of changes in physical activity. The ability to boost energy expenditure and thermogenesis via VMH melanocortin activation offers a novel therapeutic avenue. This research could pave the way for new pharmacological strategies targeting the brain to combat metabolic disorders such as obesity and type 2 diabetes by increasing calorie burning. Future research should focus on identifying specific downstream pathways and translating these findings into human trials.


melanotan-ii melanocortin agonist mc4r protocol relevant
Source: pubmed:27126579 · Ingested 2026-04-03 · Digest: gemini-2.5-flash